Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Natural Product Reports | journal | 2.753 Q1 | 211 | 53 | 128 | 9245 | 950 | 123 | 7.73 | 174.43 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 6.223 Q1 | 70 | 8 | 44 | 1340 | 537 | 44 | 8.71 | 167.50 | |
3 | Frontiers in Medicinal Chemistry | book series | 7 | 27 | 0 | 4364 | 0 | 0 | 0.00 | 161.63 | ||
4 | Progress in Medicinal Chemistry | journal | 0.849 Q2 | 38 | 8 | 23 | 1253 | 67 | 20 | 2.60 | 156.63 | |
5 | Critical Reviews in Toxicology | journal | 1.537 Q1 | 129 | 29 | 69 | 4381 | 317 | 63 | 3.80 | 151.07 | |
6 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.446 Q1 | 99 | 24 | 48 | 3594 | 210 | 45 | 4.00 | 149.75 | |
7 | Advances in Molecular Toxicology | book series | 18 | 6 | 0 | 761 | 0 | 0 | 0.00 | 126.83 | ||
8 | Current Drug Metabolism | journal | 1.835 Q1 | 122 | 65 | 123 | 7593 | 861 | 117 | 6.92 | 116.82 | |
9 | Expert Opinion on Emerging Drugs | journal | 0.708 Q2 | 54 | 46 | 116 | 5338 | 331 | 116 | 3.06 | 116.04 | |
10 | Studies in Natural Products Chemistry | book series | 0.313 Q3 | 49 | 24 | 87 | 2773 | 37 | 27 | 0.18 | 115.54 | |
11 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 1.205 Q1 | 50 | 10 | 17 | 1137 | 75 | 17 | 4.41 | 113.70 | |
12 | Handbook of Experimental Pharmacology | journal | 0.446 Q1 | 110 | 181 | 153 | 20554 | 115 | 149 | 0.75 | 113.56 | |
13 | Recent Patents on Cardiovascular Drug Discovery | journal | 30 | 27 | 0 | 2843 | 0 | 0 | 0.00 | 105.30 | ||
14 | Toxicological Reviews | journal | 0.695 Q2 | 49 | 20 | 75 | 2097 | 178 | 67 | 1.71 | 104.85 | |
15 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.319 Q3 | 100 | 69 | 51 | 6961 | 76 | 51 | 1.49 | 100.88 | |
16 | Advanced Drug Delivery Reviews | journal | 2.778 Q1 | 366 | 107 | 365 | 10459 | 3360 | 303 | 8.61 | 97.75 | |
17 | Cellular and Molecular Life Sciences | journal | 2.857 Q1 | 261 | 258 | 782 | 24555 | 4185 | 776 | 5.10 | 95.17 | |
18 | Neurotherapeutics | journal | 1.932 Q1 | 136 | 53 | 109 | 4821 | 655 | 98 | 6.01 | 90.96 | |
19 | Inflammation and Allergy - Drug Targets | journal | 55 | 32 | 0 | 2799 | 0 | 0 | 0.00 | 87.47 | ||
20 | Current Pharmacogenomics | journal | 0.183 Q3 | 12 | 33 | 56 | 2875 | 34 | 56 | 0.61 | 87.12 | |
21 | Expert Opinion on Biological Therapy | journal | 0.910 Q2 | 102 | 118 | 426 | 10116 | 1358 | 420 | 3.26 | 85.73 | |
22 | Expert Opinion on Therapeutic Targets | journal | 1.268 Q1 | 106 | 84 | 204 | 7122 | 651 | 195 | 3.07 | 84.79 | |
23 | Expert Opinion on Drug Delivery | journal | 0.588 Q1 | 133 | 65 | 97 | 5359 | 207 | 93 | 2.13 | 82.45 | |
24 | Expert Opinion on Investigational Drugs | journal | 1.075 Q1 | 117 | 138 | 426 | 11102 | 1507 | 414 | 3.45 | 80.45 | |
25 | Expert Review of Vaccines | journal | 0.810 Q2 | 105 | 76 | 265 | 6009 | 679 | 243 | 2.24 | 79.07 | |
26 | Journal of International Peacekeeping | journal | 0.100 Q4 | 14 | 10 | 39 | 790 | 2 | 37 | 0.05 | 79.00 | |
27 | Advances in Phytomedicine | book series | 15 | 43 | 0 | 3377 | 0 | 0 | 0.00 | 78.53 | ||
28 | Current Pharmaceutical Biotechnology | journal | 1.000 Q1 | 97 | 60 | 145 | 4656 | 459 | 129 | 3.08 | 77.60 | |
29 | Marine Drugs | journal | 0.589 Q2 | 159 | 18 | 39 | 1338 | 66 | 36 | 1.84 | 74.33 | |
30 | Expert Opinion on Pharmacotherapy | journal | 0.565 Q2 | 93 | 226 | 676 | 15502 | 1536 | 663 | 2.27 | 68.59 | |
31 | Clinical Pharmacokinetics | journal | 1.534 Q1 | 184 | 82 | 241 | 5255 | 1530 | 238 | 5.41 | 64.09 | |
32 | Expert Opinion on Drug Discovery | journal | 84 | 65 | 0 | 4028 | 0 | 0 | 0.00 | 61.97 | ||
33 | Expert Opinion on Therapeutic Patents | journal | 0.456 Q3 | 88 | 117 | 362 | 7106 | 494 | 350 | 1.53 | 60.74 | |
34 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.336 Q3 | 56 | 70 | 237 | 4210 | 273 | 236 | 1.19 | 60.14 | |
35 | BioDrugs | journal | 0.786 Q2 | 79 | 42 | 125 | 2488 | 383 | 123 | 3.70 | 59.24 | |
36 | Toxin Reviews | journal | 0.242 Q3 | 54 | 29 | 90 | 1716 | 84 | 83 | 0.96 | 59.17 | |
37 | Chinese Medicine | journal | 56 | 4 | 0 | 235 | 0 | 0 | 0.00 | 58.75 | ||
38 | Current Opinion in Investigational Drugs | journal | 1.120 Q1 | 83 | 132 | 484 | 7673 | 1527 | 446 | 3.01 | 58.13 | |
39 | Current Opinion in Drug Discovery and Development | journal | 1.404 Q1 | 85 | 67 | 245 | 3875 | 1246 | 229 | 5.43 | 57.84 | |
40 | Neuropsychopharmacology | journal | 2.724 Q1 | 249 | 285 | 762 | 16343 | 4804 | 734 | 6.33 | 57.34 | |
41 | Current Opinion in Molecular Therapeutics | journal | 0.908 Q2 | 67 | 69 | 270 | 3935 | 701 | 241 | 2.55 | 57.03 | |
42 | Drug Safety | journal | 1.352 Q1 | 140 | 93 | 262 | 5283 | 1202 | 245 | 4.54 | 56.81 | |
43 | Molecular Diagnosis and Therapy | journal | 68 | 43 | 186 | 2421 | 548 | 184 | 2.88 | 56.30 | ||
44 | Particle and Fibre Toxicology | journal | 1.458 Q1 | 119 | 16 | 14 | 852 | 74 | 13 | 5.29 | 53.25 | |
45 | Psychopharmacology | journal | 1.892 Q1 | 214 | 366 | 1156 | 19456 | 5043 | 1107 | 4.18 | 53.16 | |
46 | Trends in Pharmacological Sciences | journal | 4.402 Q1 | 244 | 104 | 356 | 5460 | 3669 | 324 | 10.55 | 52.50 | |
47 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.767 Q2 | 99 | 94 | 386 | 4860 | 1009 | 382 | 3.03 | 51.70 | |
48 | Molecular Diversity | journal | 0.739 Q2 | 63 | 55 | 160 | 2825 | 386 | 153 | 2.11 | 51.36 | |
49 | Xenobiotica | journal | 0.512 Q3 | 89 | 71 | 242 | 3596 | 475 | 242 | 1.93 | 50.65 | |
50 | Chemico-Biological Interactions | journal | 0.710 Q2 | 144 | 138 | 413 | 6896 | 856 | 409 | 1.80 | 49.97 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®